RSS   Newsletter   Contact   Advertise with us

Medmira announces changes to board of directors

Staff writer | Halifax, NS, Canada – MedMira Inc., a developer and manufacturer of vertical flow rapid diagnostics, announced that it has appointed Marvyn Robar and Colin MacGillivray as directors to serve until the next annual shareholder meeting.[break]


The Board elected Mr. Robar as the Company's first non
| May 7, 2014
MedMiraMay 7, 2014, Halifax, NS, Canada – MedMira Inc., a developer and manufacturer of vertical flow rapid diagnostics, announced that it has appointed Marvyn Robar and Colin MacGillivray as directors to serve until the next annual shareholder meeting.
The Board elected Mr. Robar as the Company's first non-executive Chairman. Hermes Chan, CEO of MedMira, who served as interim Chairman, will remain as the member of the Board.

Mr. Robar brings extensive experience to the role of Chairman of Board with more than 35 years in both the private and public sectors. Prior to his retirement from the Government of Nova Scotia 2013, Mr. Robar served as the Vice President, Investment, Department of Economic and Rural Development and Tourism, and as President of the Nova Scotia Strategic Opportunities Fund Inc., an investment fund. He routinely provided advice and recommendations to the Executive Council of the Province of Nova Scotia, ministers, and deputy ministers across a broad range of departments on files and portfolios.

After completing a BSc in chemistry/math and working as a chemist at the Nova Scotia Research Foundation, Mr. Robar returned to Dalhousie University, obtained an MBA and subsequently, went on to join PricewaterhouseCoopers and earn his Chartered Accountancy designation.

The Board also appointed Colin MacGillivray as a Director.

Dr. MacGillivray has more than 20 years of experience including finance and operating experience in life sciences across multiple geographies with Elan Pharmaceuticals Inc., Lundbeck Inc. (the US subsidiary of H. Lundbeck A/S, Denmark) and Biolytical Laboratories, along with broader experience from a range of other industries. Dr. MacGillivray is a Member of the Institute of Chartered Accountants in England & Wales having qualified with PricewaterhouseCoopers.

He received his Ph.D. from the Department of Animal & Plant Sciences, University of Sheffield following undergraduate studies at the University of Edinburgh.

Shou-Ching Tang retired from the Board of Directors after 12 years of service.


 LATEST MOVES FROM Nova Scotia 


MORE INSIDE POST